Are central nervous system drugs displaying anti-inflammatory activity suitable for early treatment of COVID-19?
Are central nervous system drugs displaying anti-inflammatory activity suitable for early treatment of COVID-19? Folia Neuropathol. 2021; 59(2):113-120.